2025 CMO Excellence in Green Chemistry Award
Olon S.p.A is awarded on their innovative work, “Recombinant DNA technology and chimeric protein expression for sustainable production of therapeutic peptides by microbial fermentation.” Leveraging their expertise in microbial fermentation, Olon S.p.A. has developed a flexible manufacturing platform for the synthesis of peptide therapeutics. This novel technology synthesizes peptides using microbial fermentation (rDNA expression), leading to reduced solvent and toxic material usage, as well as minimizing excess building blocks by using no protecting groups. This improves the overall PMI compared to the existing Solid Phase Peptide Synthesis (SPPS) methods. Moreover, as part of their platform, a Master Cell Bank (MCB) significantly reduces the lead time for manufacturing since the cells can be logarithmically proliferated to maximize the yield of desired product in the fermenter. They are adapting their novel Fermentation Platform towards commercial GLP-1 peptides and non-GLP-1 peptides. Olon’s novel Fermentation Platform can help address the growing global demand for peptide therapeutics while employing the principles of green chemistry. The team consists of Piera Fonte, Gian Luca Bertetti, Antonella Malcangi, Alberto Oppedisano, Mattia Stucchi, Marianna Lembo, Guido Trione, Eleonora Amante, Giuseppe Borrelli, and Giuseppe Ferrante.
